Model
Edge
Alnylam Pharmaceuticals, Inc.
0001446125
Filing type
4
Filing date
Feb 16, 2026
Updated
Feb 17, 2026 ยท 5:27 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership